A unique collection of 1406 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;Potential to find new GPCR drug candidates by screening against orphan GPCRs;Bioactivity and safety confirmed by pre-clinical research and clinical trials, and some of them are approved by FDA;Targets include 5-HT receptor, dopamine receptor, opioid receptor, adrenergic receptor, mGluR, Cannabinoid receptor, ETA-receptor, etc;Detailed compound information with structure, target, activity, IC50 value, and biological activity description;Structurally diverse, medicinally active, and cell permeable;NMR and HPLC validated to ensure high purity and quality;